Literature DB >> 24006414

Multipotent stromal cells skew monocytes towards an anti-inflammatory function: the link with key immunoregulatory molecules.

Sara M Melief, Sacha B Geutskens, Willem E Fibbe, Helene Roelofs.   

Abstract

Keywords:  HLA-G molecules; anti-inflammatory; monocytes; multipotent stromal cells; skew

Mesh：

Substances：

Year:  2013        PMID： 24006414      PMCID： PMC3762117          DOI： 10.3324/haematol.2013.093864

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation.

Authors:  Moïra François; Raphaëlle Romieu-Mourez; Mengyang Li; Jacques Galipeau
Journal:  Mol Ther       Date:  2011-09-20       Impact factor: 11.454

2.  A simple method for identifying bone marrow mesenchymal stromal cells with a high immunosuppressive potential.

Authors:  Roberta Rizzo; Giacomo Lanzoni; Marina Stignani; Diana Campioni; Francesco Alviano; Francesca Ricci; Pier Luigi Tazzari; Loredana Melchiorri; Sergio Zaccaria Scalinci; Antonio Cuneo; Laura Bonsi; Francesco Lanza; Gian Paolo Bagnara; Olavio R Baricordi
Journal:  Cytotherapy       Date:  2010-12-20       Impact factor: 5.414

3.  Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells.

Authors:  Alma J Nauta; Alwine B Kruisselbrink; Ellie Lurvink; Roel Willemze; Willem E Fibbe
Journal:  J Immunol       Date:  2006-08-15       Impact factor: 5.422

4.  IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages.

Authors:  P Allavena; L Piemonti; D Longoni; S Bernasconi; A Stoppacciaro; L Ruco; A Mantovani
Journal:  Eur J Immunol       Date:  1998-01       Impact factor: 5.532

5.  Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness.

Authors:  Shaul Beyth; Zipora Borovsky; Dror Mevorach; Meir Liebergall; Zulma Gazit; Hadi Aslan; Eithan Galun; Jacob Rachmilewitz
Journal:  Blood       Date:  2004-10-28       Impact factor: 22.113

6.  Multipotent stromal cells induce human regulatory T cells through a novel pathway involving skewing of monocytes toward anti-inflammatory macrophages.

Authors:  Sara M Melief; Ellen Schrama; Martijn H Brugman; Machteld M Tiemessen; Martin J Hoogduijn; Willem E Fibbe; Helene Roelofs
Journal:  Stem Cells       Date:  2013-09       Impact factor: 6.277

7.  Multipotent stromal cells skew monocytes towards an anti-inflammatory interleukin-10-producing phenotype by production of interleukin-6.

Authors:  Sara M Melief; Sacha B Geutskens; Willem E Fibbe; Helene Roelofs
Journal:  Haematologica       Date:  2013-01-24       Impact factor: 9.941

8.  Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G.

Authors:  Aisha Nasef; Noelle Mathieu; Alain Chapel; Johanna Frick; Sabine François; Christelle Mazurier; Asma Boutarfa; Sandrine Bouchet; N-Claude Gorin; Dominique Thierry; Loïc Fouillard
Journal:  Transplantation       Date:  2007-07-27       Impact factor: 4.939

9.  Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism.

Authors:  Farida Djouad; Louis-Marie Charbonnier; Carine Bouffi; Pascale Louis-Plence; Claire Bony; Florence Apparailly; Céline Cantos; Christian Jorgensen; Danièle Noël
Journal:  Stem Cells       Date:  2007-05-17       Impact factor: 6.277

10.  Umbilical cord-derived mesenchymal stromal cells modulate monocyte function to suppress T cell proliferation.

Authors:  Antony J Cutler; Vasanti Limbani; John Girdlestone; Cristina V Navarrete
Journal:  J Immunol       Date:  2010-10-27       Impact factor: 5.422
View more
  9 in total

Review 1.  Adipose-Derived Mesenchymal Stromal Cells in Regenerative Medicine: State of Play, Current Clinical Trials, and Future Prospects.

Authors:  Jérôme Laloze; Loïc Fiévet; Alexis Desmoulière
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-06-02       Impact factor: 4.730

2.  An Evaluation of the Stemness, Paracrine, and Tumorigenic Characteristics of Highly Expanded, Minimally Passaged Adipose-Derived Stem Cells.

Authors:  Oula El Atat; Diane Antonios; George Hilal; Nabil Hokayem; Joelle Abou-Ghoch; Hussein Hashim; Rim Serhal; Clara Hebbo; Mayssam Moussa; Nada Alaaeddine
Journal:  PLoS One       Date:  2016-09-15       Impact factor: 3.240

Review 3.  The Future of Bronchopulmonary Dysplasia: Emerging Pathophysiological Concepts and Potential New Avenues of Treatment.

Authors:  Jennifer J P Collins; Dick Tibboel; Ismé M de Kleer; Irwin K M Reiss; Robbert J Rottier
Journal:  Front Med (Lausanne)       Date:  2017-05-22

4.  Pluripotent Nontumorigenic Adipose Tissue-Derived Muse Cells have Immunomodulatory Capacity Mediated by Transforming Growth Factor-β1.

Authors:  María L Gimeno; Florencia Fuertes; Andres E Barcala Tabarrozzi; Alejandra I Attorressi; Rodolfo Cucchiani; Luis Corrales; Talita C Oliveira; Mari C Sogayar; Leticia Labriola; Ricardo A Dewey; Marcelo J Perone
Journal:  Stem Cells Transl Med       Date:  2016-08-02       Impact factor: 6.940

Review 5.  Metabolism in Human Mesenchymal Stromal Cells: A Missing Link Between hMSC Biomanufacturing and Therapy?

Authors:  Xuegang Yuan; Timothy M Logan; Teng Ma
Journal:  Front Immunol       Date:  2019-05-08       Impact factor: 7.561

6.  Adipose-derived mesenchymal stromal cells modulate experimental autoimmune arthritis by inducing an early regulatory innate cell signature.

Authors:  Mercedes Lopez-Santalla; Ramon Menta; Pablo Mancheño-Corvo; Juan Lopez-Belmonte; Olga DelaRosa; Juan A Bueren; Wilfried Dalemans; Eleuterio Lombardo; Marina I Garin
Journal:  Immun Inflamm Dis       Date:  2016-04-04

Review 7.  The Immunomodulatory Effects of Mesenchymal Stem Cells in Prevention or Treatment of Excessive Scars.

Authors:  Bommie Florence Seo; Sung-No Jung
Journal:  Stem Cells Int       Date:  2015-12-29       Impact factor: 5.443

Review 8.  Review of stem cells as promising therapy for perianal disease in inflammatory bowel disease.

Authors:  Francis E Dailey; Erica P Turse; Maliha Naseer; Jack D Bragg; Veysel Tahan
Journal:  World J Transplant       Date:  2018-08-09

9.  Comparative Proteomic Analysis Identifies EphA2 as a Specific Cell Surface Marker for Wharton's Jelly-Derived Mesenchymal Stem Cells.

Authors:  Ashraf Al Madhoun; Sulaiman K Marafie; Dania Haddad; Motasem Melhem; Mohamed Abu-Farha; Hamad Ali; Sardar Sindhu; Maher Atari; Fahd Al-Mulla
Journal:  Int J Mol Sci       Date:  2020-09-03       Impact factor: 5.923
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.